Search Remote Jobs

Senior Director, Biostatistics

đź•’ May 22

Apply Now
Find Similar Remote Jobs

📊 Check your resume score for this job

Improve your chances of getting an interview by checking your resume score before you apply.

Logo of Sabin Vaccine Institute

Sabin Vaccine Institute

51 - 200 employees

Founded 1993

⚕️ Healthcare Insurance

🧬 Biotechnology

🤝 Non-profit

đź’° $35M Grant on 2023-01

Healthcare Insurance • Biotechnology • Non-profit

Sabin Vaccine Institute is dedicated to improving global health by ensuring access to life-saving vaccines. The institute focuses on research and development of new vaccines for some of the world’s most pressing diseases, including cholera, HPV, malaria, Marburg, and Ebola. Through innovative programs and partnerships, Sabin aims to enhance immunization capacities and vaccine acceptance within communities, ultimately striving to make vaccination accessible to all, especially vulnerable populations.

đź“‹ Description

• Provide strategic leadership for statistical activities supporting late-stage vaccine development programs • Ensure statistical rigor across clinical development, translational sciences, and CMC • Provide strategic input to senior leadership on statistical implications of development strategies • Lead statistical strategy for Phase 2/3 clinical trials • Oversee statistical deliverables from CROs and external partners • Partner with clinical and translational teams to support immunobridging models • Guide statistical design and analysis of pivotal nonclinical studies • Manage relationships with external vendors, key opinion leaders, and regulatory agencies • Mentor and develop internal statisticians and other team members

🎯 Requirements

• Minimum of a graduate degree in Biostatistics, Statistics, or related field; doctoral degree strongly preferred • 14+ years of biostatistics experience in pharma/biotech, with substantial leadership in late-phase clinical development • Expertise in clinical trial design, regulatory submissions, and statistical modeling in vaccines or infectious diseases. • Experience with immunobridging, logistical regression methods, and Bayesian or frequentist modeling • Working knowledge of CMC statistics, assay validation, and nonclinical study design. • Proficiency in statistical programming (e.g., SAS, R, Python); experience with CDISC standards is a plus • Proven leadership, communication, and cross-functional collaboration skills

🏖️ Benefits

• medical, dental, and vision coverage • flexible spending accounts • flexible vacation and sick leave • employer-paid life and disability insurance • 11 federal holidays • end-of-year winter break • employer-matching 401(k) plan

Apply Now

Similar Jobs

đź•’ May 22

DLB Associates

201 - 500

🎮 Gaming

📚 Education

⚡ Productivity

Electrical Associate Director at DLB Associates leading design activities and optimizing staffing in the Design Department. Key role in organizational development and operational excellence for the Electrical team.

đź•’ May 22

DLB Associates

201 - 500

🎮 Gaming

📚 Education

⚡ Productivity

BIM Associate Director managing electrical BIM operations and collaborating with leadership at DLB Associates. Leading BIM strategy and team performance within design department.

đź•’ May 22

Associate Director developing Thought Leader strategy for oncology brand LOQTORZI. Building advocacy and collaborating with key stakeholders in the head and neck cancer space.

đź•’ May 21

Celcuity

51 - 200

🧬 Biotechnology

đź’Š Pharmaceuticals

Associate Director overseeing clinical safety operations and vendor management at Celcuity. Leading compliance and regulatory reporting in drug safety and pharmacovigilance.

🇺🇸 United States – Remote

đź’µ $165k - $197k / year

🔥 Funding within the last year

đź’° $500M Post-IPO Debt - Celcuity on 2025-09

⏰ Full Time

đźź  Senior

đź‘” Director

đź•’ May 21

Praxis

11 - 50

🧬 Biotechnology

⚕️ Healthcare Insurance

🔬 Science

Senior Director leading execution of trade and distribution strategy for CNS therapies at Praxis. Overseeing launch readiness for rare diseases and specialty markets.